2011
DOI: 10.1017/s1368980010003320
|View full text |Cite
|
Sign up to set email alerts
|

The prevalence of metabolic syndrome in Latin America: a systematic review

Abstract: Objective: To assess the available data on the prevalence of metabolic syndrome (MS) in Latin-American countries. Design: Systematic review. Searches were carried out in PubMed, ISIWeb, SCielo and Redalyc, using 'metabolic syndrome x' and 'prevalence' as keywords for titles and/or abstracts. Articles selected were cross-sectional studies in Latin-American countries, whose main objective was to study MS and whose study population is described below. MS must be determined using Adult Treatment Panel III criteria… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

12
88
7
30

Year Published

2012
2012
2022
2022

Publication Types

Select...
6
3
1

Relationship

0
10

Authors

Journals

citations
Cited by 161 publications
(137 citation statements)
references
References 41 publications
12
88
7
30
Order By: Relevance
“…These increases are not occurring homogeneously within the region. In our study, the prevalence of metabolic syndrome overall was substantially higher than the values reported for the Latin American region in a recent comprehensive review: 25·3 % in women and 23·2 % in men (4) . However, of the nine countries in our study only Mexico was included in the review.…”
Section: Discussioncontrasting
confidence: 88%
“…These increases are not occurring homogeneously within the region. In our study, the prevalence of metabolic syndrome overall was substantially higher than the values reported for the Latin American region in a recent comprehensive review: 25·3 % in women and 23·2 % in men (4) . However, of the nine countries in our study only Mexico was included in the review.…”
Section: Discussioncontrasting
confidence: 88%
“…A recent study, which evaluated the occurrence of the syndrome in Latin American countries, found that rates varied between 18.8% and 43.3%, averaging 24.9% across countries; however, the data obtained may not reflect the real values due to the lack of information available in some of the regions (9) .…”
Section: Discussionmentioning
confidence: 97%
“…El síndrome metabólico (SM) es una condición endógena que incrementa la probabilidad de desarrollar enfermedades de índole hepático, cardiovascular y metabólico (1), cuya prevalencia a nivel mundial se ha incrementado de forma importante durante las últimas décadas (2,3).…”
Section: Introductionunclassified